In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 55 for your search:
Drug:  vandetanib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00097, 2011-004701-24, NCT01496313

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and older
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00032, 6474IL/0032, NCT00312377

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00057, EUDRACT No. 2006-000259-16, NCT00364351

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00058, NCT00410761

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00044, EUDRACT Number 2006-002384-12, NCT00404924

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00036, EUDRACT No. 2006-003695-35, NCT00418886

7.

Phase: Phase III
Type: Natural history/Epidemiology, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00088, 2010-023428-26, NCT01298323

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-06-C-0063, NCI-P6680, NCT00293566

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 06-377, IRUSZACT0018, NCT00441142

10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 5 to 18
Sponsor: NCI
Protocol IDs: 070189, 07-C-0189, NCI-07-C-0189, NCT00514046

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: 090089, 09-C-0089, NCT00923247

12.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00098, NCT01661179

13.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: CAN-NCIC-IND145, ZENECA-6474IL/0004, IND145

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-03090, ZENECA-6474IL/0003, NCT00059722

15.

Phase: Phase II
Type: Treatment
Status: Unknown
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0405022-01, ZENECA-D4200C00007, ZENECA-D4200C007A, NCT00093392

16.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00008, NCT00098345

17.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00068, NCT00358956

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-0825, NCT00410189

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00048, NCT00454116

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 06-283, NCT00459043

21.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-0929, NCT00402896

22.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00047, NCT00500292

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 20 to 120
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00072, NCT00508001

24.

Phase: Phase II
Type: Tissue collection/Repository, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D4200C00079, NCT00537095

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 080020, 08-C-0020, NCI-08-C-0020, NCI-P07148, NCT00566995
1    
New Search